Cong S, Fang L W, Bao H L, Feng Y J, Wang N, Yin P, Li Y C, Duan X N, Zhou M G
Division of Cancer Control and Prevention, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
Division of Vital Statistics and Death Surveillance, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Jun;37(6):773-7. doi: 10.3760/cma.j.issn.0254-6450.2016.06.006.
To analyze the disease burden of thyroid cancer in the Chinese population, in 1990 and 2013.
Data on China from the Global Burden of Disease 2013 (GBD2013) was used to analyze the related parameters as mortality, prevalence,years of life lost due to premature mortality (YLL), years lived with disability (YLD) and disability-adjusted life years (DALY) of thyroid cancer in China in 1990 and 2013 among all the Chinese population.
There were 33 939 thyroid cancer patients identified in 2013 (7 146 men and 26 793 women), with an increase of 21 898 patients than the number in 1990. The incidence rate of thyroid cancer increased by 181.86%. The incidence rates of thyroid cancer showed an increase in females but a decrease in males. In 2013, 4 974 people (2 292 men and 2 682 women) died of thyroid cancer, with an increase of 1 810 patients, compared with the figures in 1990. The mortality rate of thyroid cancer in 2013 decreased by 14.29%, compared with the figures in 1990. The mortality rate of thyroid cancer decreased in females while the incidence rate in males showed an increase. The incidence rates increased with age in females, reaching a peak at the 50-54 years old group. The mortality rate of thyroid cancer increased with age. The DALY, YLL and YLD due to thyroid cancer appeared as 13.35, 11.42 and 1.93 ten thousand person years, respectively, in 2013. Between 1990 to 2013, the age-standardized rates on DALY, YLL and YLD decreased from 10.33/100 000 to 8.84/100 000, from 9.60/100 000 to 7.61/100 000 and increased from 0.72/100 000 to 1.23/100 000, respectively. In 2013 the top three incidence rates were recorded in Qinghai, Xinjiang and Fujian provinces while the lowest was in Tibet. Compared with those in 1990, the incidence rates increased in all the provinces except for Tianjin. The top three high mortality rates were recorded in Qinghai, Hong Kong and Fujian and the lowest was also in Tibet. The mortality rates increased in five provinces.
Compared with those in 1990, the incidence of thyroid cancer increased, but the mortality decreased in 2013. Although significant decrease of DALY due to thyroid cancer was seen in 2013, the YLD burden was still increasing.
分析1990年和2013年中国人群甲状腺癌的疾病负担。
利用2013年全球疾病负担研究(GBD2013)中中国的数据,分析1990年和2013年中国全体人群中甲状腺癌的死亡率、患病率、过早死亡所致生命损失年(YLL)、带病生存年(YLD)和伤残调整生命年(DALY)等相关参数。
2013年共确诊甲状腺癌患者33939例(男性7146例,女性26793例),比1990年增加了21898例。甲状腺癌发病率上升了181.86%。甲状腺癌发病率女性上升而男性下降。2013年,4974人(男性2292人,女性2682人)死于甲状腺癌,与1990年相比增加了1810例。2013年甲状腺癌死亡率与1990年相比下降了14.29%。甲状腺癌死亡率女性下降而男性发病率上升。女性发病率随年龄增长而上升,在50 - 54岁年龄组达到峰值。甲状腺癌死亡率随年龄增长而上升。2013年,甲状腺癌所致的伤残调整生命年、过早死亡所致生命损失年和带病生存年分别为13.35、11.42和1.93万人年。1990年至2013年,伤残调整生命年、过早死亡所致生命损失年和带病生存年的年龄标准化率分别从10.33/10万降至8.84/10万,从9.60/10万降至7.61/10万,从0.72/10万升至1.23/10万。2013年发病率最高的三个省份是青海、新疆和福建,最低的是西藏。与1990年相比,除天津外所有省份的发病率均上升。死亡率最高的三个地区是青海、香港和福建,最低的也是西藏。五个省份的死亡率上升。
与1990年相比,2013年甲状腺癌发病率上升但死亡率下降。尽管2013年甲状腺癌所致伤残调整生命年显著下降,但带病生存年负担仍在增加。